Clinical research technology and CRO services
Your clinical study deserves more than disconnected software and fragmented service providers. ValidTrials combines clinical research infrastructure with professional study services, so a sponsor can move from scientific planning to controlled data, statistical analysis and research documentation with one accountable partner. A platform license and a CRO contract are not the same purchase.
Protocol, sites, data, analysis and the report can name the same study and the same version.
The software does not replace a statistician, a monitor or a regulatory professional. Those roles are engaged in a scope of work.
The same record can hold a kit, a specimen or a dose. The regulation that applies still depends on the product and the country.
Changes keep a person, a time and a reason. An analysis names its snapshot.
Technology only, CRO services only, or both. Responsibilities are written in the agreement, not assumed from a subscription.
A demonstration uses synthetic data. You can watch a workflow that matches your design before a proposal.
We do not publish scores against other vendors. You compare coordination, handoffs and accountability on your own requirements.
No savings percentage, no automatic compliance, and no statement that the system is a validated production environment for every sponsor.
Design, countries, sites and what you need us to do.
Synthetic participants, forms and a snapshot.
Software access and professional services are listed apart.
A proposal states deliverables, milestones and what remains yours.
A sponsor should be able to follow one decision from the protocol sentence that created it to the number in the report. The chain below is the one we configure. A later stage cites the version it used. The software does not promote a draft to approved on its own.
Software does not replace scientific judgment. The roles below are contracted in the scope, or they stay with you. We do not staff a role the agreement does not name, and we do not publish a headcount.
A device or an algorithm is part of the intervention. The protocol has to say what it is for, which version was used, what a clinically important error is, and what the reference standard was. Regulation (EU) 2017/745 and ISO 14155:2020 are the texts a device team reads. This website is not a certified reading of them, and a Class IIb label does not set the sample size.
The claim the investigation is built to examine.
Safety and clinical performance, defined before the look.
Independent of the model when the study is about an algorithm.
A later model is a new version, not a silent update of the enrolled one.
Receipt, use, return or destruction, on the same study as the form.
Missed urgency and false reassurance, and whether the result is the same across the groups you named.
Verification by a qualified person is a service. It is not an automatic certificate.
This is an invented device study. It is not a result and not a participant. Protocol version 2.0 defines a performance endpoint. The eCRF field “index result” is tied to that activity. Query 14 asks the site to confirm a unit. Snapshot SYN-LOCK-01 is the copy the analysis uses. The approved run produces one figure. The report sentence quotes that figure and names the snapshot. If any link in that chain is missing, the number is not ready to quote.
Oversight is the role you are given, not a separate product. Today that means accounts on the study. There is not yet a distinct read-only sponsor role, so the permissions are agreed. A demonstration can show milestones, open queries, monitoring notes and document status on synthetic data. We do not publish a screenshot and call it your study.
Only if the scope says so.
No. Registration as a CRO is not a certificate that a particular study is compliant.
Yes. That is the technology-only path.
Software on this page is what the product can record today. CRO work is a professional service under a separate scope. Neither is a certification, a regulator’s approval, or proof that a study is compliant because the software was used. A qualified person still signs consequential decisions.
The conversation is about your study design and what the software can and cannot do today.
Clinical trial management for drugs, devices, and diagnostics. EU and US regulatory packages from one record. CAREPOI CRO, registered with EOF 16 November 2026.
© 2026 CAREPOI · ValidTrials · Helsinki, EU